Ruben Rizzi
Company: BioNTech AG
Job title: Senior Vice President - Global Regulatory Affairs
Seminars:
Developing a Fully Individualized mRNA Cancer Immunotherapy: Regulatory Innovation & Challenges 9:00 am
Lessons learned from the development of fully individualized mRNA immunotherapy across multiple tumor types Key questions to identify the most appropriate development strategy Navigating an evolving regulatory landscape and identifying the areas of uncertaintyRead more
day: Conference Day Two
Roundtable Discussion:Individualized Cancer Vaccines: Development Strategies for Neoantigen Selection, Clinical Development & Regulatory Approval 1:30 pm
How to determine the best clinical setting for individualized cancer therapies for the easiest path through the clinic What are the different combination therapy strategies with personalized cancer vaccines for positive patient response? What is the dosing schedule in trials for personalized cancer vaccines for the most effective patient response?Read more
day: Conference Day Two